Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Instil Bio Inc TIL

Instil Bio, Inc. is a clinical-stage biopharmaceutical company focused on developing a pipeline of novel therapies. The Company seeks to in-license/acquire and develop novel therapeutic candidates in diseases with significant unmet medical need. Its first such program is an engineered tumor infiltrating lymphocyte (TIL), cell therapy for the treatment of cancer. It is engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor (CoStAR), platform. The Company's lead CoStAR-TIL product candidate, ITIL-306, expresses a CoStAR molecule designed to recognize folate receptor alpha (Fra), a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC and renal cancer. CAR-T and TCR-T therapies are cell products composed of T cells that have been genetically engineered to recognize a specific cancer-related antigen on the surface of tumor cells.


NDAQ:TIL - Post by User

Bullboard Posts
Post by Goldmetalon Aug 27, 2011 1:49pm
496 Views
Post# 18986267

William Sheriff

William Sheriff has purchased another 40,000 shares on the open market and exercised 712,000 warrants in the past 10 days. Golden Predator Corp. (GPD)As of August 26th, 2011Filing Date Transaction Date Insider Name Ownership Type Securities Nature of transaction # or value acquired or disposed of Unit Price Aug 26/11 Aug 25/11 Sheriff, William Morris Direct Ownership Common Shares 10 - Acquisition in the public market 30,000 $1.000Aug 26/11 Aug 25/11 Sheriff, William Morris Direct Ownership Common Shares 10 - Acquisition in the public market 10,000 $1.020 Aug 16/11 Aug 12/11 Sheriff, William Morris Direct Ownership Warrants 54 - Exercise of warrants 712,000
.800 Aug 16/11 Aug 12/11 Sheriff, William Morris Direct Ownership Warrants 54 - Exercise of warrants -712,000
.800 https://canadianinsider.com/coReport/allTransactions.php?ticker=gpd
Bullboard Posts